Dimerix Limited (ASX: DXB), is a clinical stage, biotechnology company that focusses on the development of new therapeutic treatments using its proprietary drug discovery platform, Receptor-Heteromer Investigation Technology (HIT).

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK